Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
Cencora, Inc. (NYSE: COR) has announced the date for its Fourth Quarter Fiscal 2024 Earnings Release. The company will release its results on Wednesday, November 6, 2024, before the New York Stock Exchange opens. A conference call to discuss the results is scheduled for 8:30 a.m. ET on the same day.
The call will feature Robert P. Mauch, President & CEO, and James F. Cleary, Executive VP & CFO. Investors can access the live webcast via investor.cencora.com. For telephone access, US and Canada participants should dial (833) 470-1428, while international callers should use +1 (404) 975-4839, with access code 272044.
Replays will be available via webcast and telephone. Cencora, ranked #10 on the Fortune 500, is a global pharmaceutical solutions organization with over $250 billion in annual revenue.
Cencora, Inc. (NYSE: COR) ha annunciato la data per il suo Rilascio dei Risultati del Quarto Trimestre Fiscale 2024. L'azienda pubblicherà i risultati il mercoledì 6 novembre 2024, prima dell'apertura della Borsa di New York. È prevista una conferenza telefonica per discutere i risultati alle 8:30 a.m. ET dello stesso giorno.
Alla chiamata parteciperanno Robert P. Mauch, Presidente e CEO, e James F. Cleary, VP Esecutivo e CFO. Gli investitori possono accedere alla diretta webcast tramite investor.cencora.com. Per l'accesso telefonico, i partecipanti dagli Stati Uniti e dal Canada dovrebbero comporre il numero (833) 470-1428, mentre i chiamanti internazionali dovrebbero utilizzare +1 (404) 975-4839, con codice di accesso 272044.
Le registrazioni saranno disponibili tramite webcast e telefono. Cencora, classificata al #10 nella Fortune 500, è un'organizzazione globale di soluzioni farmaceutiche con oltre 250 miliardi di dollari di fatturato annuale.
Cencora, Inc. (NYSE: COR) ha anunciado la fecha para el Informe de Resultados del Cuarto Trimestre Fiscal 2024. La compañía publicará sus resultados el miércoles 6 de noviembre de 2024, antes de la apertura de la Bolsa de Nueva York. Se programó una conferencia telefónica para discutir los resultados a las 8:30 a.m. ET el mismo día.
La llamada contará con la participación de Robert P. Mauch, Presidente y CEO, y James F. Cleary, VP Ejecutivo y CFO. Los inversionistas pueden acceder a la transmisión en vivo a través de investor.cencora.com. Para acceso telefónico, los participantes de EE. UU. y Canadá deben marcar (833) 470-1428, mientras que los llamadores internacionales deben usar +1 (404) 975-4839, con el código de acceso 272044.
Las repeticiones estarán disponibles a través de webcast y teléfono. Cencora, clasificada en el #10 de la Fortune 500, es una organización global de soluciones farmacéuticas con más de 250 mil millones de dólares en ingresos anuales.
Cencora, Inc. (NYSE: COR)은 2024 회계 연도 4분기 실적 발표 일정을 발표했습니다. 회사는 2024년 11월 6일 수요일 뉴욕 증권 거래소가 열리기 전에 결과를 발표할 예정입니다. 같은 날 오전 8:30 ET에 결과에 대해 논의할 컨퍼런스 콜이 예정되어 있습니다.
콜에는 Robert P. Mauch 사장 겸 CEO와 James F. Cleary 전무 부사장 겸 CFO가 참석합니다. 투자자들은 investor.cencora.com을 통해 생중계 웹캐스트에 접속할 수 있습니다. 전화로 접속하려면 미국 및 캐나다 참가자는 (833) 470-1428로, 국제 통화자는 +1 (404) 975-4839를 사용해야 하며, 접근 코드는 272044입니다.
재생은 웹캐스트 및 전화로 제공됩니다. Fortune 500에서 #10위에 랭크된 Cencora는 연간 2500억 달러 이상의 수익을 올리는 글로벌 제약 솔루션 조직입니다.
Cencora, Inc. (NYSE: COR) a annoncé la date de son Publication des Résultats du Quatrième Trimestre Fiscal 2024. La société publiera ses résultats le mercredi 6 novembre 2024, avant l'ouverture de la Bourse de New York. Une conférence téléphonique pour discuter des résultats est prévue à 8h30 ET le même jour.
La conversation comprendra Robert P. Mauch, Président et CEO, ainsi que James F. Cleary, VP Exécutif et CFO. Les investisseurs peuvent accéder à la diffusion en direct via investor.cencora.com. Pour l'accès téléphonique, les participants des États-Unis et du Canada devraient composer le (833) 470-1428, tandis que les appelants internationaux doivent utiliser le +1 (404) 975-4839, avec le code d'accès 272044.
Les rediffusions seront disponibles par webcast et téléphone. Cencora, classée au #10 du Fortune 500, est une organisation mondiale de solutions pharmaceutiques avec plus de 250 milliards de dollars de revenus annuels.
Cencora, Inc. (NYSE: COR) hat das Datum für seine Ergebnisveröffentlichung für das vierte Quartal 2024 bekannt gegeben. Das Unternehmen wird seine Ergebnisse am Mittwoch, den 6. November 2024, vor der Eröffnung der New Yorker Börse bekannt geben. Eine Telefonkonferenz zur Diskussion der Ergebnisse ist für 8:30 Uhr ET am selben Tag geplant.
An dem Anruf nehmen Robert P. Mauch, Präsident und CEO, und James F. Cleary, Executive VP und CFO, teil. Anleger können die Live-Übertragung über investor.cencora.com erreichen. Für den telefonischen Zugang sollten Teilnehmer aus den USA und Kanada die Nummer (833) 470-1428 wählen, während internationale Anrufer +1 (404) 975-4839 verwenden sollten, mit dem Zugangscode 272044.
Wiederholungen werden über Webcast und Telefon verfügbar sein. Cencora, die auf Platz 10 der Fortune 500 rangiert, ist eine globale Organisation für pharmazeutische Lösungen mit einem Jahresumsatz von über 250 Milliarden Dollar.
- Cencora is ranked #10 on the Fortune 500 and #24 on the Global Fortune 500
- The company has more than $250 billion in annual revenue
- None.
Participating in the conference call will be:
Robert P. Mauch, President & Chief Executive Officer
James F. Cleary, Executive Vice President & Chief Financial Officer
The live call will be webcast via the Company’s website at investor.cencora.com. Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call.
To access the call via telephone from within
Replays of the call will be made available via telephone and webcast. A replay of the webcast will be posted on investor.cencora.com approximately one hour after the completion of the call and will remain available for one year. The telephone replay will also be available approximately one hour after the completion of the call and will remain available for 7 days. To access the telephone replay from within
Please check the website investor.cencora.com for updates regarding the timing of the live webcasts and for replay information.
About Cencora
Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #24 on the Global Fortune 500 with more than
View source version on businesswire.com: https://www.businesswire.com/news/home/20240930756620/en/
Bennett S. Murphy
Senior Vice President, Head of Investor Relations and Treasury
610-727-3693
Bennett.Murphy@cencora.com
Source: Cencora
FAQ
When will Cencora (COR) release its Q4 2024 earnings?
What time is Cencora's (COR) Q4 2024 earnings conference call?
How can investors access Cencora's (COR) Q4 2024 earnings call?
Who will be participating in Cencora's (COR) Q4 2024 earnings call?
